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ON A SUNNY SPRING DAY, 13 students at the School of Law begin
a two-hour discussion of one of the most difficult questions in
bioethics: Under what circumstances can U.S. researchers ethically
conduct clinical trials on human subjects?
Assistant Professor Leslie Meltzer Henry kicks off the seminar
with zest: How many students, she asks, have been subjects in a
scientific study? Nearly all the students raise their hands. Somewhat
sheepishly, they describe participation in studies as undergrads,
mostly to earn a few bucks.
But the students knew what they were signing up for. What
about instances where subjects aren’t aware of their participation
in a study? The Bioethics Seminar, taught by Henry, who is also
an associate faculty member at the Johns Hopkins Berman
Institute of Bioethics, is geared toward critical and philosophically
grounded discussion of some of the most controversial topics at
the intersection of law and medicine: physician-assisted suicide,
abortion, assisted reproduction, allocation of scarce health care
resources, gifting and selling body parts, termination of life-
sustaining treatment.
Offered through UMDLaw’s nationally recognized Law &
Health Care Program, the course draws upon guest instructors
from the medical and nursing schools on UMB’s campus. The
interdisciplinary nature of the course is reflected in the back-
grounds of its students, many of whom have come to law school
after pursuing medical careers.
“Students come in with very different experiences,” Henry says.
“We have doctors, nurses, and students with advanced degrees in
public health and public policy. The goal is to provide them with
the intellectual tools they need to analyze the challenging ethical
issues they will confront in the health care arena.”
On this day, with the issue of human research subjects at the
fore, Henry takes students on a tour of what she calls “a parade of
horribles,” three notorious scandals in U.S. clinical research history:
The Tuskegee Syphilis Study, The Willowbrook Hepatitis Studies,
and The Jewish Chronic Disease Hospital Case.
Everyone in the class agrees that Tuskegee violates today’s
standards for informed consent. For 40 years, the U.S. Public
Health Service tracked 399 poor African-American sharecroppers
in Alabama with syphilis, withholding treatment, to watch the
natural progression of the disease.
The outrage over Tuskegee and other questionable uses of
human subjects in experimental research led to the Belmont
Report in 1978, which set forth principles for ethically conducting
research. Henry asks students to apply the Belmont framework to
the Willowbrook case, in which researchers at a state-run school in
Staten Island intentionally infected mentally disabled children, age
3 to 11, with the hepatitis virus in an attempt to study it and create
a vaccine against it.
Her question: “Did the study have a favorable risk/benefit
ratio for the population?” One student raises concerns: “It’s a lot
to put [vulnerable] children through to find out information
that could have been found elsewhere.” Another disagrees:
Nearly all children who resided at Willowbrook were infected with
hepatitis A within six months anyway, due to unsanitary living
conditions. “There’s an argument to be made that people already
were suffering.” Another student agrees, and points out that the
children intentionally infected with hepatitis might “see the doctor
more frequently, get better medical care.”
The dialogue allows students to explore the moral underpinnings
of health law and policy in a way that best simulates what happens
in the real world, students say. The format is important for interdis-
ciplinary subjects such as bioethics, where ethical issues at the
intersection of medicine, biology, law, public health, and public
policy arise.
Third-year student Keith Shebairo, a physician by training,
says the classroom dialogue simulates what happens in a real
hospital, where he has served on an ethics panel. On such panels,
doctors, nurses, social workers, hospice staff, lawyers, and others
wrestle with gut-wrenching decisions. “They must discuss things
openly and ultimately make a decision.” The key, he says, is to
respect and value different points of views. And that’s what
happens in Henry’s class.
“Just because I have a medical background doesn’t make my
opinion any more valuable,” says Shebairo. “We have to be open to
hearing each other and respecting each other’s perspectives. That’s
how we arrive at good decisions.”
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